PARD OTC
Poniard Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$24M
+31.6% ▲
Capital Expenditures
$7K
+66.7% ▲
5Y CAGR: -39.2%
Free Cash Flow
-$24M
+31.6% ▲
Dividends Paid
$0
+100.0% ▲
Buybacks
$192K
+61.6% ▲
Net Change in Cash
-$15M
+48.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$23M | -$33M | -$49M | -$46M | -$30M |
| Depreciation & Amort. | $4M | $1M | $2M | $1M | $1M |
| Stock-Based Comp. | $0 | $0 | $7M | $7M | $9M |
| Change in Working Capital | $87K | $2M | $6M | -$3M | -$7M |
| Other Non-Cash Items | $2M | $5M | $379K | $4M | $2M |
| Operating Cash Flow | -$17M | -$25M | -$33M | -$35M | -$24M |
| — Investing Activities — | |||||
| Capital Expenditures | -$5M | -$6M | -$391K | -$21K | -$7K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$10M | -$104M | -$46M | -$53M | -$7M |
| Investment Sales | $0 | $52M | $81M | $54M | $31M |
| Other Investing | $110K | $3M | $0 | $112K | $58K |
| Investing Cash Flow | -$15M | -$56M | $34M | $1M | $24M |
| — Financing Activities — | |||||
| Net Debt Issuance | $14M | -$4M | $14M | -$8M | -$20M |
| Stock Repurchased | $0 | $0 | -$500K | -$500K | -$192K |
| Dividends Paid | -$500K | -$500K | -$500K | -$500K | $0 |
| Other Financing | $856K | -$145K | $91K | $820K | $123K |
| Financing Cash Flow | $73M | $65M | $14M | $6M | -$14M |
| Net Change in Cash | $41M | -$15M | $15M | -$28M | -$15M |
| Cash End of Period | $44M | $29M | $44M | $16M | $1M |
| Free Cash Flow | -$23M | -$30M | -$34M | -$36M | -$24M |